The nation’s leading private equity advisory firm Avendus is looking to raise a substantial $350 million for its next investment fund, according to multiple sources familiar with the matter.
With over two decades of experience in venture capital and private equity dealmaking across India, Avendus has established itself as one of the premier names in the industry. Their network of relationships and proven track record of backing successful companies makes them a go-to partner for institutional investors seeking exposure to India’s booming startup ecosystem.
It is understood the new fund will continue Avendus’ strategy of investing growth capital in technology companies across diverse sectors such as fintech, healthcare, education and more. With a pool of $350 million, the fund aims to scale some of India’s most promising startups and help accelerate their expansion plans both within India and other international markets.
Should Avendus hit its fundraising target, the new fund would be 25% larger than their previous $280 million vehicle raised back in 2019. This highlights growing demand from Limited Partners for allocation to India’s tech sector which has seen unprecedented growth and produced over 100 unicorns. Avendus has an impressive portfolio of their own including companies like Pharmeasy, Curefit and Quess Corp, giving investors confidence.
